NDC 17856-0060-01 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0060
- Requested NDC
- 17856-0060-01
- Package NDCs from labels
- 17856-0060-1, 17856-0060-3, 17856-0060-2, 17856-0060-4, 17856-0060-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEGESTROL ACETATE ORAL SUSPENSION, USP | ATLANTIC BIOLOGICALS CORP. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-05-09 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-3 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
| 17856-0060-4 | 2024-01-30 | MEGESTROL ACETATE ORAL SUSPENSION, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0060-1 | Megestrol Acetate | 10 mL in 1 CUP | SUSPENSION | 10 | 3 | |
| 17856-0060-2 | Megestrol Acetate | 20 mL in 1 CUP | SUSPENSION | 20 | 3 | |
| 17856-0060-3 | Megestrol Acetate | 72 in 1 BOX | SUSPENSION | 72 | 3 | |
| 17856-0060-4 | Megestrol Acetate | 50 in 1 BOX | SUSPENSION | 50 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0060 | MEGESTROL ACETATE SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250524_01119031-9943-4afb-8b45-cb71682f0482.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin Children | GLYCERIN | Rising Pharma Holdings, Inc. | 80a5a944-2882-4f8d-a955-ef827cead5f0 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Megestrol Acetate | MEGESTROL ACETATE | Kesin Pharma Corporation | 3bc8708e-a52d-fda2-e063-6294a90a0fbc | 2025-09-02 | Warnings, Adverse reactions | ANDA075671 860225 TJ2M0FR8ES |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Stool Softener | DOCUSATE SODIUM | BJWC (Berkley & Jensen / BJ's) | 330758d2-fc1a-50ce-e063-6294a90a7db1 | 2025-08-19 | Warnings | F05Q2T2JA0 |
| Medique Medi Seltzer | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Unifirst First Aid Corporation | 528da9d9-2a52-4c16-b7b2-61b3eee1abea | 2025-08-19 | Warnings | 2968PHW8QP |
| Upside Down Pain Relief | BENZOCAINE, GLYCERIN | Fridababy, LLC | 31c2cd25-1fec-5ec5-e063-6394a90a24b4 | 2025-08-15 | Warnings | PDC6A3C0OX |
| Sennosides and Docusate Sodium | SENNOSIDES AND DOCUSATE SODIUM | American Health Packaging | 4b84d5d7-43cf-47bb-af59-088550c3a0bc | 2025-08-12 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | Good Sense (Geiss, Destin & Dunn, Inc.) | 8066a52d-e683-47c1-905c-290d2d427acf | 2025-08-12 | Warnings | F05Q2T2JA0 |
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | PDC6A3C0OX |
| Durma DynaGel | DURMA DYNAGEL | Dynarex Corporation | 3bcbe314-98ca-78f1-e063-6394a90a13ad | 2025-08-07 | Warnings | PDC6A3C0OX |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Unimed | 3bcd8394-f486-d306-e063-6294a90a4e9a | 2025-08-07 | Warnings | PDC6A3C0OX |
| Prolaxa | DOCUSATE SODIUM 250MG | Advanced Rx of Tennessee, LLC | 3ba0c0d9-9e6f-a2e6-e063-6394a90a202d | 2025-08-05 | Warnings | F05Q2T2JA0 |
| Dulcolax Stool Softener | DOCUSATE SODIUM | Chattem, Inc. | 86cb7102-3585-4757-9c37-5bf9776bbe63 | 2025-08-01 | Warnings | F05Q2T2JA0 |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | KC Pharmaceuticals, Inc. | 3bc03d54-6b31-5921-e063-6294a90af599 | 2025-08-01 | Warnings | PDC6A3C0OX |
| Docu Liquid | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | f4ed0721-3be9-4108-a6c9-dbbe115249e9 | 2025-07-31 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM, SENNOSIDES | Granulation Technology, Inc. | f36c509e-b93b-4d7f-a18a-41e585369a15 | 2025-07-30 | Warnings | F05Q2T2JA0 |
| Megestrol Acetate | MEGESTROL ACETATE | Xttrium Laboratories, Inc. | 3169f883-4076-32ce-e063-6394a90a4925 | 2025-07-24 | Warnings, Adverse reactions | 860225 TJ2M0FR8ES |
| Doctor Butler Hemorrhoid and Fissure Advanced Formula | GLYCERIN 37.5%, LANOLIN 12.5%, LIDOCAINE 4%, ZINC OXIDE 5% | Beyond Health, PA | d2a769e2-afd0-aed2-e053-2995a90ad429 | 2025-07-23 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.